These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 34842903)

  • 1. Human Papillomavirus Vaccination and Trends in Cervical Cancer Incidence and Mortality in the US.
    Tabibi T; Barnes JM; Shah A; Osazuwa-Peters N; Johnson KJ; Brown DS
    JAMA Pediatr; 2022 Mar; 176(3):313-316. PubMed ID: 34842903
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Trends in human papillomavirus vaccination among women aged 27 to 45 years, from 2017 to 2019.
    Kulkarni A; Chen L; Melamed A; Hershman DL; Wright JD
    Am J Obstet Gynecol; 2022 Apr; 226(4):568-570.e1. PubMed ID: 34953774
    [No Abstract]   [Full Text] [Related]  

  • 3. Prophylactic HPV vaccination for the prevention of cervical cancer.
    Hernandez BY
    Hawaii Med J; 2007 Jul; 66(7):190-1. PubMed ID: 17879858
    [No Abstract]   [Full Text] [Related]  

  • 4. In 30 years, gender-neutral vaccination eradicates oncogenic human papillomavirus (HPV) types while screening eliminates HPV-associated cancers.
    Lehtinen M; Gray P; Louvanto K; Vänskä S
    Expert Rev Vaccines; 2022 Jun; 21(6):735-738. PubMed ID: 35404177
    [No Abstract]   [Full Text] [Related]  

  • 5. The case for catch-up human papillomavirus vaccination in at-risk populations: Rural communities and survivors of pediatric and young adult cancers.
    Kacew AJ; Grimes AC; Roth M; Teoh D; Landier W; Strohbehn GW; Paskett ED
    CA Cancer J Clin; 2020 Nov; 70(6):518-519. PubMed ID: 33063840
    [No Abstract]   [Full Text] [Related]  

  • 6. Reply to The case for catch-up human papillomavirus vaccination in at-risk populations: Rural communities and survivors of pediatric and young adult cancers.
    Saslow D; Andrews KS; Manassaram-Baptiste D; Smith RA; Fontham ETH
    CA Cancer J Clin; 2020 Nov; 70(6):519-520. PubMed ID: 33063839
    [No Abstract]   [Full Text] [Related]  

  • 7. Estimating the impact of human papillomavirus (HPV) vaccination on HPV prevalence and cervical cancer incidence in Mali.
    Tracy L; Gaff HD; Burgess C; Sow S; Gravitt PE; Tracy JK
    Clin Infect Dis; 2011 Mar; 52(5):641-5. PubMed ID: 21252142
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bandicoots, bonobos, and boys: papillomavirus and vaccination strategies.
    Grose C
    Pediatrics; 2009 Apr; 123(4):1244-5. PubMed ID: 19336384
    [No Abstract]   [Full Text] [Related]  

  • 9. One in four California adolescent girls have had human papillomavirus vaccination.
    Grant D; Kravitz-Wirtz N; Breen N; Tiro JA; Tsui J
    Policy Brief UCLA Cent Health Policy Res; 2009 Feb; (PB2009-3):1-6. PubMed ID: 19288623
    [No Abstract]   [Full Text] [Related]  

  • 10. Do you approve of spending $300 million on HPV vaccination?: no.
    Lippman A; Boscoe M; Scurfield C
    Can Fam Physician; 2008 Feb; 54(2):175, 177, 179, 181. PubMed ID: 18272623
    [No Abstract]   [Full Text] [Related]  

  • 11. Human papillomavirus vaccination for adult women.
    Roteli-Martins CM; Magno V; Santos ALF; Teixeira JC; Nilma AN; Fialho SCAV
    Rev Bras Ginecol Obstet; 2022 Jun; 44(6):631-635. PubMed ID: 35820426
    [No Abstract]   [Full Text] [Related]  

  • 12. Low affordability may limit the effect of cervical cancer vaccination in central and eastern European countries.
    Zubor P; Danko J; Kajo K; Szunyogh N
    J Clin Oncol; 2007 Dec; 25(34):5534-7. PubMed ID: 18048836
    [No Abstract]   [Full Text] [Related]  

  • 13. [Human papillomavirus vaccination : pharmacovigilance data].
    Dib F; Launay O
    Rev Prat; 2020 Jan; 70(1):96-98. PubMed ID: 32877039
    [No Abstract]   [Full Text] [Related]  

  • 14. Primary and secondary prevention of cervical cancer--opportunities and challenges.
    Markowitz LE; Unger ER; Saraiya M
    J Natl Cancer Inst; 2009 Apr; 101(7):439-40. PubMed ID: 19318638
    [No Abstract]   [Full Text] [Related]  

  • 15. HPV vaccination associated with decreased cervical cancer incidence and mortality.
    Caskey R
    J Pediatr; 2022 Jun; 245():246-249. PubMed ID: 35718380
    [No Abstract]   [Full Text] [Related]  

  • 16. Screening for cervical cancer and human papillomavirus vaccination in Israel: recommendations.
    Bornstein J; Fisher WA; Ginsberg GM; Shavit O; Schejter E; Diaz M; Bosch FX
    Vaccine; 2013 Nov; 31 Suppl 8():I58-60. PubMed ID: 24229721
    [No Abstract]   [Full Text] [Related]  

  • 17. HPV vaccine: a cornerstone of female health.
    Temte JL
    Am Fam Physician; 2007 Jan; 75(1):28, 30. PubMed ID: 17225700
    [No Abstract]   [Full Text] [Related]  

  • 18. [Human Papillomavirus: screening of cervical and anal cancers].
    Pache B; Jacot-Guillarmod M; Hübner M; Mathevet P
    Rev Med Suisse; 2022 Oct; 18(800):1950-1955. PubMed ID: 36259700
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Real-World Effectiveness of Human Papillomavirus Vaccination Against Cervical Cancer.
    Kjaer SK; Dehlendorff C; Belmonte F; Baandrup L
    J Natl Cancer Inst; 2021 Oct; 113(10):1329-1335. PubMed ID: 33876216
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Asia Pacific: cervical cancer screening and human papillomavirus vaccination policy and delivery.
    Shah KV
    Vaccine; 2008 Aug; 26 Suppl 12(Suppl 12):iii-iv. PubMed ID: 18945419
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.